Records containing: Recurrent Adult Brain Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase I Study of Vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]) in Combination With Temozolomide in Patients With Malignant Gliomas
-
CLINICAL_TRIALS study record update · 2024-11-06Drug Distribution and Pharmacodynamic Study of Pulsatile Lapatinib in Surgically Accessible EGFR-Amplified Recurrent High-Grade Glioma
-
CLINICAL_TRIALS study record update · 2021-10-28Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma
-
CLINICAL_TRIALS study record update · 2019-04-25Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
-
CLINICAL_TRIALS study record update · 2018-05-23Phase I/Comparative Randomized Phase II Trial of TRC105 Plus Bevacizumab Versus Bevacizumab in Bevacizumab-Naive Patients With Recurrent Glioblastoma Multiforme
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-01-09A Phase II, Multi-institutional Trial of NOVO-TTF-100A, BCNU and Bevacizumab for GBM in First Relapse
-
CLINICAL_TRIALS study record update · 2017-05-19A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (Anaplastic Gliomas and Glioblastoma)
-
CLINICAL_TRIALS study record update · 2017-03-27Dynamic Contrast Enhanced Steady State T1-Weighted Perfusion MRI (DCE MRI): Characterization of Intracranial Lesions
-
CLINICAL_TRIALS study record update · 2016-10-04A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-04-18Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
-
CLINICAL_TRIALS study record update · 2015-06-02A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2015-04-28Pilot Biomarker Study of the Integrin AlphavBeta3 Antagonist Cilengitide (EMD121974) in Combination With Sunitinib
-
CLINICAL_TRIALS study record update · 2015-04-15A Phase Ib Study of Cediranib in Combination With Cilengitide in Patients With Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2015-01-06Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
-
CLINICAL_TRIALS study record update · 2014-12-23High-Dose Vorinostat With Radiation Therapy in the Treatment of Recurrent Glioma
-
CLINICAL_TRIALS study record update · 2014-12-23A Phase 1, Pharmacokinetic and Pharmacodynamic Study of the Combination of RO4929097 and Cediranib in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-10-06Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
-
CLINICAL_TRIALS study record update · 2013-05-01A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma